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Abstract
Introduction
As US Hispanic populations are at higher risk than non-Hispanics for cardiovascular disease
and Type 2 diabetes targeted interventions are clearly needed. This paper presents the four
years results of the Vida Sana Program (VSP), which was developed and is implemented by
a small clinic serving mostly Spanish-speaking, limited literacy population.
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Methods
The eight-week course of interactive two-hour sessions taught by Navegantes, bilingual/
cultural community health workers, was delivered to participants with hypertension, or high
lipids, BMI, waist circumference, glucose or hemoglobin A1C (A1C). Measures, collected by
Navegantes and clinic nurses, included blood chemistries, blood pressure, anthropometry,
and an assessment of healthy food knowledge.

Results
Most participants (67%) were female, Hispanic (95%), and all were 18 to 70 years of age. At
baseline, close to half of participants were obese (48%), had high waist circumference
(53%), or elevated A1C (52%), or fasting blood glucose (57%). About one third had
high blood pressure (29%) or serum cholesterol (35%), and 22% scored low on the knowledge assessment. After the intervention, participants decreased in weight (-1.0 lb), BMI
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(-0.2 kg/m2), WC (-0.4 inches), and cholesterol (-3.5 mg/dl, all p<0.001). Systolic blood
pressure decreased (-1.7 mm Hg, p<0.001), and the knowledge score increased (6.8 percent, p<0.001).

Discussion
VSP shows promising improvements in metabolic outcomes, similar to other programs with
longer duration or higher intensity interventions. VSP demonstrates an important model for
successful community-connected interventions.

Introduction
Hispanic populations in the United States are at higher risk of behavioral and metabolic risk
factors and experience lower access to health screening and healthcare services than other
racial or ethnic groups in the United States [1]. Hispanic populations are also at higher risk for
developing cardiovascular disease [2] and Type 2 diabetes due to the confluence of certain risk
factors in the population [3]. For example, Hispanics have the highest risk among US racial/
ethnic groups for developing Metabolic Syndrome (MetS), a condition combining hyperglycemia/insulin resistance, obesity and dyslipidemia [4–6]. In particular, according to 2007–2012
data, Mexican American women and men have higher fasting blood glucose compared with
Non-Hispanic Whites (NHW), and Mexican American women also have higher risk of high
waist circumference and lower HDL than NHW women [6]. Higher risk of MetS and Type 2
diabetes for Hispanic women in the Northeastern US compared to NHW women has been
documented [1]. These disparities clearly highlight a need for targeted intervention, though
what kind of intervention and which behaviors to target is less clear.
Several important behavioral risk factors associated with MetS that might be natural
targets for intervention have been measured with US Hispanics as previously described [7].
Smoking and Alcohol consumption are lower in this population than for NHWs [8]. Initial
dietary habits of recent Hispanic immigrants are healthier than NHWs, but change to be lesshealthy, with acculturation [8, 9], which is consistent with findings other research highlighting
higher consumption of sugar sweetened beverages, and fewer fruits and vegetables among Hispanic, compared to NHW Americans [10]. Additionally, sedentary behaviors and physical
inactivity are higher among Hispanic Americans compared to NHW [8]. These dietary and
physical activity behaviors may be important factors to address in lifestyle intervention
programs.
Community-based interventions have the potential to inform and engage community
members at risk for MetS-associated diseases about how to manage their diseases and modify
their diet and exercise regimens, which may result in lower risks of morbidity and cost of care.
Clı́nica Esperanza/Hope Clinic (CEHC), located on the West Side of Providence, Rhode
Island, serves a low-income, often uninsured, largely Spanish-speaking, and literacy-limited
population. CEHC personnel developed a lifestyle intervention called the Vida Sana Program
(VSP) to engage patients and community members in the prevention and treatment of MetS
and related diseases by encouraging healthier lifestyles [11]. A previous manuscript reported
data for the pilot year of the VSP intervention at CEHC [12]. Data for years 2–5 of VSP with
enrollment dates between January 2014 and June 2017 are presented here, documenting the
clinical outcomes (n = 641) and providing support for the implementation of culturally sensitive, linguistically appropriate programs for low health literacy populations.
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Methods
The methods utilized in VSP have been documented in detail previously [11]. The protocol for
this work was reviewed by, "Ethical and Independent Review Services," in April 2016, then
annually since that time. The IRB determined that this protocol (18021–01) meets the criterion
for exemption. The data collected for this manuscript was not from the medical charts, but was
collected independently for evaluation of Vida Sana. Researchers only had access to deidentified data for the purposes of this analysis. In brief, VSP was designed to serve the mostly low
health-literate and reading-limited clinic population, to be sensitive to the cultural, social and
linguistic factors that affect CEHC patients and to enable patients and community members to
take ownership of their own health. The interactive eight-week course is taught by trained
bilingual/bi-cultural community health workers called Navegantes who have an ongoing relationship with many CEHC patients as they also provide a source of support in navigating the
healthcare system in other roles within CEHC.
Navegantes are available during all clinical encounters CEHC, serving as liaisons for most
patients between patients and the healthcare system by offering support relating to insurance
options, specialty referrals, and social determinants of health. They are specifically trained to
provide nutritional and chronic disease information and advice, which may include offering
enrollment into the Vida Sana Program and can act as advocates for the individual patients
navigating the healthcare system and the clinic.

Recruitment of participants and eligibility criteria
CEHC medical providers recruit patients into VSP if they have or are at risk for hypertension,
have elevated blood lipids, BMI, waist circumference, fasting blood glucose or Hemoglobin
A1C (A1C). Specific and detailed guidelines for inclusion or exclusion are not applied; providers are able to refer any patients who they determine to be at risk for metabolic syndrome or
who would benefit from the program. Recruitment also extends to community members who
seek out the VSP program after word-of-mouth information from other participants. Most
groups take place at the clinic itself, but non-CEHC participants are also recruited into VSP
classes when a class is planned in another location accessible to the clinic population, such as
community sites and religious centers. As VSP is a clinic-based program, not a research study,
we did not calculate an apriori sample size based on anticipated power, but included in this
analysis all participants enrolled during the stated time frame.
VSP incentivizes attendance at weekly sessions by offering grocery store gift cards and
healthy snacks. One $10 gift card is given out upon enrollment, another at the week 8 session,
and a third at their 12-week appointment to check clinical measures. We encourage participants to use these gift cards to buy ingredients to make the healthy recipes that are demonstrated during class. Volunteers at the clinic offer childcare during the classes in order to help
parents of young children attend.

Intervention
VSP consists of one- to two-hour group sessions over 8 weeks delivered by Navegantes in
small groups (10–18 participants) in English and Spanish, following a standard VSP curriculum containing specific learning objectives for each session. The materials called Thumbs Up™
includes workbooks and presentation materials and facilitates learning through simple, easyto-understand terminology and vivid imagery. More details about the intervention, including
recruitment and training of Navegantes are published elsewhere [11]. The groups involve
approximately 70% discussion and 30% sharing of information. Content of the sessions
includes information about the health conditions and related clinical indicators associated
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with Type 2 diabetes, hypertension and hypercholesterolemia, along with practical knowledge
and skills associated with improving diet, physical activity, medication compliance, and
decreasing sedentary time. During the week between sessions, the Navegante reaches out to
each participant by telephone to remind them of the location, confirm their attendance and
reinforce their session content and their personal goals. The Navegantes create a mutually supportive environment similar to a “social club” for participants through the use of group games
and story-telling. Through interactive learning and celebration of participants’ achievements
with certificates, the Navegantes create a group environment in which participants can share
stories, empathize about challenges and celebrate successes.

Evaluation measures
Navegantes and CEHC nurses conducted all measures during the first session attended by the
participant. The measures include anthropometries, blood chemistries and an assessment of
diet, health and wellness knowledge.
• Height, Weight and BMI: Participants are weighed without shoes on a scale dedicated to the
VSP. Height is measured on the stadiometer attached to the dedicated scale, also without
shoes. BMI is calculated using these measurements as weight (kg) divided by height (meters)
squared.
• Fasting Blood Glucose: Blood glucose testing is conducted using the Assure Platinum 7-Second Blood Glucose Meter [13]. Participants were asked to fast for at least four hours prior to
the blood draw.
• Hemoglobin A1C (A1C): Testing is done using the Alere Afinion, which offers accurate
results from 1.5 μL of finger stick or venous whole blood [14].
• Cholesterol: Fasting cholesterol is tested using the mobile Alere Cholestech LDX [15].
• Blood Pressure: Systolic and diastolic blood pressure measurements are taken by trained
staff members using a calibrated sphygmomanometer that is dedicated to VSP. Blood pressure is measured twice, with at least five minutes between measurements. If there is a significant difference between the first two readings, blood pressure is measured again at the end
of the session, and this value is used.
• Waist Circumference: A dedicated paper measuring tape is used to measure patients’ waist
circumference just above the hip bones, at the widest point.
Follow-up measures were taken at the end of the intervention (8 weeks). (A second round
of follow-up measures were taken at 12 weeks after the intervention start for any participants
who were able to come back, but those data are not included.) Participants also complete a
pre- and post-intervention knowledge assessment that tests their recognition of healthy food
labels, food choices and clinical numbers. Scores for this tool are presented as a percentage of
the 20 items presented. The Navegantes administer the test verbally, using PowerPoint slides
with graphics and photos to illustrate the questions, while participants record their responses
on an answer sheet. This assessment consists of several tasks: 1) choosing which is the healthier
of two food options, 2) classifying blood pressure readings as “healthy” or “unhealthy”, and 3)
comparing the salt or sugar content of two different foods or food labels.

Data analysis
To assess baseline risk for each blood chemistry, anthropometry or blood pressure value, high
risk was defined as: BMI>30 kg/m2 [16], waist circumference >35 cm (women) or WC >40
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cm (men) [16], systolic blood pressure >130 mmHg, diastolic blood pressure > 80 mmHg
[17], A1C >5.6 g/dl [18], glucose >100 mg/dl [19], cholesterol >200 mg/dl [20]. Demographics and baseline clinical risk variables were compared between those with and without followup data using chi square (Table 1). Differences in baseline clinical variables were examined by
demographics of age group, sex and primary language spoken with ANOVA models (Table 2).
Change in each measure was assessed with paired t-tests for the sample with complete pre and
post data as measured (Table 3). Also change in each measure was assessed for just participants
identified as having high risk values at baseline, also using paired t-tests (Table 3). Missing follow-up data were imputed by carrying forward the baseline value for each participant (also
Table 3). Changes between baseline and Week 8 data were assessed by demographic characteristics for both crude (complete cases only) and for imputed data using ANOVA models.

Results
Of the 641 enrolled VSP participants at baseline (Table 1), 399 (62%) completed the program
and were assessed at the end of the 8 weeks. At baseline, participants were well distributed
among age groups from 18 to over 65. Most participants (67%) were female, Hispanic (95%),
and Spanish speaking (92%). Similar proportions reported being publically insured (27%) or
uninsured (32%), with a large group (32%) not responding, and fewer (9%) reporting being
privately insured. Participants identified their country of origin as Guatemala (34.9%), Dominican Republic (28.4%), Puerto Rico (8%), Columbia (4.4%) or the US (3.7%) with all others
(Mexico, Bolivia, El Salvador, Honduras, Venezuela, Peru, Argentina, Chile, Cuba, Brazil,
Haiti, Philippines, Burundi, Cape Verde, Gibralter and Senegal) reporting in lower percentages, and 3.9% not responding (Data not shown).
Many participants had baseline clinical characteristics that are consistent with chronic disease risk. Over half of participants (48%) were obese, with another third (34%) overweight,
with only 18% having normal weight status. Just over half (53%) had waist circumference consistent with being high risk. More than half (52%) of participants had A1C levels that are consistent with some degree of risk (>5.6%), which is consistent with the finding that over half
(57%) had fasting blood sugar greater than 100mg/dl. Just over one quarter participants had
elevated baseline blood pressure (29% for systolic (>130 mmHg) and 28% for diastolic (>80
mmHg). Over one third (35%) of participants had elevated cholesterol at baseline. Just under
one quarter of participants (22%) scored lower than 60% on the knowledge assessment.
Demographics and clinical characteristics were compared between those with and without
follow-up data to assess differential dropout, which might indicate a bias of the assessed data
toward certain characteristics. A higher proportion of women completed the program and
final evaluation than men (p<0.01). Also, people with normal A1C (p<0.05) and glucose
(p<0.05) were more likely to completed the program compared with those with elevated A1C
or glucose. No other differences in demographic or clinical characteristics were found between
those who did and did not complete the program.
Many of the baseline clinical measures differed by demographic characteristics (Table 2).
All clinical chemistry measures and anthropometries differed by age group, but not always in a
linear pattern. Other differences were found by sex, race or ethnicity.
Changes in clinical values for all participants were mixed. Table 3 shows outcomes from the
crude data set with only those participants who had baseline and follow-up data (Fig 1), as well
as the full dataset including imputation for missing values. Many changes observed for those
with complete case were found to be diminished with imputation for missing values. Results
described here focus on the outcomes after imputations. At the completion of the 8-week
intervention, participants averaged reductions in weight (1.0 lb), BMI (0.2 kg/m2), and WC
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Table 1. Demographic and metabolic characteristics of participants by status of completing the VSP program.

Age
18–34 years

All

Completed

Not Completed

Total: 641

Total: 399 (62%)

Total: 242 (38%)

n

%

n

%

n

%

124

19.3%

68

17.0%

56

23.1%

35–44 years

130

20.3%

81

20.3%

49

20.2%

45–54 years

137

21.4%

91

22.8%

46

19.0%

55–64 years

114

17.8%

75

18.8%

39

16.1%

65+ years

123

19.2%

81

20.3%

41

16.9%

Unreported

13

2.0%

3

0.8%

11

4.5%

Sex

n

%

n

%

n

%

Male

198

30.9%

105

26.3%

93

38.4%

Female

431

67.2%

292

72.9%

139

57.4%
4.1%

Unreported

12

1.9%

3

0.8%

10

Ethnicity

n

%

n

%

n

%

Hispanic

607

94.7%

384

96.2%

223

92.1%

Not Hispanic

9

1.4%

4

1.0%

5

2.1%

Unreported

25

3.9%

11

2.8%

14

5.8%

Primary Language

n

%

n

%

n

%

Spanish

589

91.9%

372

93.2%

217

89.7%

English

9

3.7%

25

3.9%

16

4.0%

1

Other

5

0.8%

5

1.3%

0

0.0%

Unreported

22

3.4%

6

1.5%

16

6.6%

Insurance Status

n

%

n

%

n

%

Insured (Public)

175

27.3%

93

23.3%

43

17.8%

Insured (Private)

58

9.0%

41

10.3%

17

7.0%

Uninsured

203

31.7%

122

30.6%

81

33.5%

205

32.0%

143

35.8%

101

41.7%

Unreported
Weight Status

n = 621

n = 399

n

%

n

%

n

%

Normal or underweight (<25 kg/m2)

114

18.4

74

18.5

40

18.0

209

33.7

131

32.8

78

35.1

Obese (>30 kg/m2)

298

48.0

194

48.6

104

46.8

Normal

n = 600

p = 0.26

p < .01

p = 0.42

p = .63

p = 0.16

n = 222

Overweight (>25 and <30 kg/m2)
Waist Circumference2

P Value

n = 390

0.844

n = 210

n

%

n

%

n

%

284

47.3

177

45.4

107

51.0

316

52.7

213

54.6

103

49.0

0.2236

< = 44 inches (men)
< = 34 inches (women)
High
>44 inches (men)
>34 inches (women)
Hemoglobin A1C

n = 240

n = 153

n = 87

n

%

n

%

n

%

Normal (< 5.6%)

113

47.1

78

51.0

35

40.2

>5.6 < 7.0%

87

36.3

57

37.3

30

34.5

>7.0 < 9.0%

27

11.3

13

8.5

14

16.1

>9.0%

13

5.4

5

3.3

8

9.2

Glucose

n = 616
n

n = 398
%

n

0.048

n = 218
%

n

%
(Continued )

PLOS ONE | https://doi.org/10.1371/journal.pone.0248473 April 1, 2021

6 / 16

PLOS ONE

Results of the ‘Vida Sana/Healthy Life’ program

Table 1. (Continued)
All

Completed

Not Completed

Total: 641

Total: 399 (62%)

Total: 242 (38%)

Normal (< = 100 mg/dl)

266

43.2

187

47.0

79

36.2

Elevated (>100 mg/dl)

350

56.8

211

53.0

139

63.8

n

%

n

%

n

%

Normal (< = 130 mmHg)

440

71.1

289

72.6

151

68.3

High (>130 mmHg)

179

28.9

109

27.4

70

31.7

Diastolic Blood Pressure

n = 618

Systolic Blood Pressure

n = 619

n = 398

n = 397

0.721

n = 221

n

%

n

%

n

%

448

72.5

285

71.8

163

73.8

High (>80 mmHg)

170

27.5

112

28.2

58

26.2

n

%

n

%

n

%

Normal (< = 200 mg/dl)

391

64.5

258

66.3

133

61.3

High (>200 mg/dl)

215

35.5

131

33.7

84

38.7

Knowledge3

n = 470

n = 606

0.0128

n = 221

Normal (< = 80 mmHg)
Cholesterol

P Value

n = 389

0.341

n = 217

n = 342

0.245

n = 128

n

%

n

%

n

%

> 60%

367

78.1

273

79.8

94

73.4

< = 60%

103

21.9

69

20.2

34

26.6

0.1723

Notes
1

Waist Circumference is assessed as high/low separately for men and women.

2

Other language includes Portuguese, Haitian Creole.
Knowledge is presented as percentage correct of 20 items.

3

https://doi.org/10.1371/journal.pone.0248473.t001

(0.4 inches) (p<0.001 for all). More than 5% of baseline weight was lost for 5.5% of the sample
(data not shown). No significant changes were found for A1C or blood glucose levels. Systolic
blood pressure decreased by 1.7 mm Hg (p<0.001), but no significant change in diastolic
blood pressure was found. Cholesterol averaged a decrease of 3.5 mg/dl (p<0.001). The knowledge score increased overall by 6.8 percent. (p<0.001).
When assessing changes in only the participants with high-risk levels of each clinical value
at baseline, improvements were found in all measures (Table 3). Decreases of 0.8 lb (weight),
0.2 kg/m2 (BMI), and 0.5 inches (WC, all p<0.001) were very similar to the overall group
changes. A1C and blood glucose both decreased (-0.3, p<0.01 and -8.3 mg/dl, p<0.001 respectively). Both systolic and diastolic blood pressure decreased (-6.0 mm Hg p<0.001 and -5.1
mm Hg respectively, p<0.001). Total cholesterol levels decreased by 12.1 mg/dl (p<0.001).
The knowledge score among those with initial low values increased by an average of 18.8
points (p<0.001).
Changes in outcomes were also examined by age group, sex and language. No differences
by demographic characteristics were found for crude changes and those with imputation of
missing values.

Discussion
VSP, a low-intensity, eight-week program delivered by CHWs (Navegantes) resulted in reductions in clinical risk factors, especially among participants with high risk levels at baseline. VSP
recruited mostly Hispanic participants, which is to be expected from a clinic serving a mostly

PLOS ONE | https://doi.org/10.1371/journal.pone.0248473 April 1, 2021

7 / 16

PLOS ONE

Results of the ‘Vida Sana/Healthy Life’ program

Table 2. Baseline clinical measures (mean (SD)) by age group, sex and language.
Baseline values by demographic characteristics.
Age Group

Sex

Language

18–34
(n = 124)

35–44
(n = 130)

45–54
(n = 137)

55–64
(n = 114)

65 and up
(n = 123)

p value Male
(n = 191)

Female
(n = 425)

p value Spanish
(n = 578)

Weight (lbs)

161.7
(38.0)

171.8
(50.0)

181.3
(40.4)

168.3
(31.7)

162.3 (28.2)

<0.001 178.4
(39.2)

165.2
(38.7)

<0.001 167.8 (35.0) 203.2
(88.0)

<0.001

BMI (kg/m2)

29.3 (7.3)

31.1(9.1)

33.8 (7.9)

31.5 (6.9)

30.9 (6.0)

<0.001 30.6 (7.2)

31.7 (7.9)

0.093

31.2 (7.1)

35.2
(16.3)

<0.05

WC (inches)

35.6 (5.3)

37.5 (5.5)

39.1 (5.4)

38.5 (4.4)

39.3 (4.5)

<0.001 38.4 (4.5)

37.8 (5.5)

0.206

37.9 (5.1)

39.8 (7.2)

0.076

AIC (mg/dl)

5.5 (1.4)

5.8 (1.2)

6.5 (1.8)

6.1 (1.0)

6.7 (1.7)

<0.01

6.4 (1.9)

5.9 (1.2)

<0.05

6.1 (1.6)

5.5 (0.62)

0.134

Glucose (mg/dl)

105.1
(38.8)

119.5
(59.6)

127.0
(61.7)

119.1
(42.8)

133.3 (62.4)

<0.01

130.0
(66.4)

116.9
(48.6)

<0.01

121.8 (56.3) 101.6
(22.5)

0.081

Systolic Blood
119.7
Pressure (mmHg) (12.1)

122.2
(12.1)

125.2
(13.2)

129.1
(15.8)

132.0 (16.1)

<0.001 127.6
(13.6)

124.5
(14.8)

<0.05

125.6 (14.5) 121.9
(14.3)

0.211

Diastolic Blood
77.4 (9.8)
Pressure (mmHg)

80.3 (8.1)

81.1 (13.9)

79.8 (11.3)

77.0 (8.9)

<0.01

80.0 (10.9) 78.7 (10.6)

0.190

78.9 (10.6)

80.8
(12.5)

0.390

Cholesterol (mg/
dl)

182.1
(38.1)

191.0
(37.8)

196.4
(39.3)

194.4
(38.6)

183.3 (38.7)

<0.01

191.9
(41.0)

0.314

190.6 (39.0) 168.0
(33.3)

<0.01

Knowledge
Assessment1

79.2 (15.6)

78.0 (17.0)

75.5 (20.6)

75.5 (18.4)

69.0 (20.0)

<0.01

72.2 (16.8) 77.0 (19.2)

<0.05

75.2 (18.7)

<0.01

188.5
(37.8)

English
(n = 25)

86.2
(13.2)

p value

Notes
Knowledge is presented as percentage correct of 20 items.

1

https://doi.org/10.1371/journal.pone.0248473.t002

Hispanic clientele. Participants representing a wide age distribution were enrolled, but as
observed for many health promotion interventions [21–23], women were more likely to participate and complete the 8-week program than men.
Many participants enrolled in VSP were at high risk with regard to weight status (34% overweight and 48% obese) and body fat distribution (53% had high WC). Additionally, higherrisk glucose intolerance was found within this population based on glucose (57% elevated) and
A1C (53% elevated). However, fewer participants had high blood pressure (29% elevated systolic, 28% elevated diastolic) or blood cholesterol (36% elevated). This pattern of risks among a
clinic sample serving mostly Spanish-speaking Hispanic participants is consistent with those
found in other research [6, 24]. Often “Hispanic” populations are depicted based on data from
Mexican American groups [6, 24], though Spanish-speaking populations from Caribbean,
Central and South American origin as in VSP may have different profiles [25]. It is also likely
that the risk pattern of program participants represents the clinical criteria by which CEHC clinicians referred patients to the VSP program.
Outcomes from VSP were comparable to similar studies aimed at addressing cardiometabolic risk factors [22, 23, 26–28]. However, changes in weight and BMI were the least noteworthy of the outcomes from VSP. The mean reduction (after imputation) in weight of 1.0 lb and
BMI by 0.2 kg/m2 is considerably more modest that that found by others. Diabetes Prevention
Program (DPP) participants, which received a much more intensive 24 week intervention
averaged a decrease of 12.3 lbs [26], and a 13-week version of DPP modified for Latinos
achieved a weight decrease of 2.5 lbs [27]. Vivamos Activos also saw a decrease of 4.6 lbs and a
decrease in BMI by 0.7 kg/m2 after the 6-month intervention delivered by CHWs [28]. No significant decrease in BMI was found in the “Latinos en Control” program, which included 12
weeks of an intensive phase (weekly sessions), and 8 months of monthly sessions [23].
Changes in BMI for VSP might also be modest as the follow-up time period was fairly
short, and weight loss was not strongly encouraged as a goal for the program, as opposed to
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Table 3. Changes in clinical measures and chemistries (mean (SD)) from baseline to week 8 with baseline values imputed for missing.
Complete Case
All Participants

Baseline High Risk Only

n

Baseline

8 weeks

Change

P value

n

Baseline

Weight (lb)

399

169.5 (41.8)

168.0 (41.9)

-1.51 (4.4)

< .001

194

193.2 (44.7)

191.7 (44.9)

8 weeks

-1.5 (5.0)

Change

<0.001

P value

BMI (kg/m2)

392

31.6 (8.2)

31.4 (8.2)

-0.3 (0.8)

< .001

187

37.8 (7.8)

37.5 (7.9)

-0.3 (1.0)

<0.001

Waist Circumference (inches)

388

38.1 (5.2)

37.4 (5.4)

-0.7 (2.0)

< .01

210

40.6 (4.5)

39.9 (5.1)

-0.8 (2.4)

<0.001

Hemoglobin A1C (%)

133

5.91 (1.2)

5.76 (0.86)

-0.15 (0.7)

< .05

56

6.8 (1.5)

6.4 (1.0)

-0.39 (1.0)

<0.01

Glucose (mg/dl)

392

115.9 (46.1)

112.8 (39.4)

-3.1 (40.0)

0.13

205

140.3 (52.3)

126.2 (47.4)

-14.1 (48.9)

<0.001

Systolic Blood Pressure (mm Hg)

397

125.6 (14.6)

122.9 (13.6)

-2.7 (12.6)

< .01

108

144.6 (10.1)

134.9 (12.6)

-9.9 (14.8)

<0.001

Diastolic Blood Pressure (mm Hg)

396

78.9 (10.1)

78.1 (9.8)

-0.7 (11.3)

0.20

112

90.1 (7.8)

82.5 (8.4)

-7.7 (10.6)

<0.001

Cholesterol (mg/dl)

371

188.8 (38.3)

183.0 (36.1)

-5.8 (27.8)

< .01

125

231.2 (23.3)

210.4 (35.2)

-20.7 (30.6)

<0.001

Knowledge

303

75.6 (18.6)

85.9 (13.9)

10.6 (17.1)

< .001

61

45.3 (11.7)

77.1 (12.4)

31.8 (18.6)

<0.001

Imputing Baseline for Missing Follow-Up Values
All Participants

Baseline High Risk Only

n

Baseline

8 weeks

Change

P value

n

Baseline

8 weeks

Change

P value

Weight (lb)

622

169.0 (39.3)

168.0 (39.4)

-1.0 (3.6)

< .001

285

191.3 (40.4)

190.5 (40.6)

- 0.8 (3.9)

<0.001

BMI (kg/m2)

608

31.3 (7.7)

31.1 (7.6)

-0.2 (0.7)

< .001

283

37.3 (7.0)

37.1 (7.0)

-0.2 (0.8)

<0.001

Waist Circumference (inches)

606

38.0 (5.2)

37.5 (5.4)

-0.4 (1.6)

< .001

316

40.6 (4.6)

40.1 (5.0)

-0.5 (2.0)

<0.001

Hemoglobin A1C (g/dl)

200

6.1 (1.5)

6.0 (1.3)

-0.2 (0.6)

0.179

87

7.1 (1.8)

6.8 (1.7)

-0.3 (0.9)

<0.01

Glucose (mg/dl)

616

120.9 (54.9)

118.9 (51.7)

-2.0 (32.0)

0.131

350

145.0 (62.5)

136.7 (61.2)

-8.3 (38.0)

<0.001

Systolic Blood Pressure (mm Hg)

618

125.5 (14.5)

123.8 (13.9)

-1.7 (10.2)

< .001

179

143.9 (9.7)

137.9 (11.8)

-6.0 (12.5)

<0.001

Diastolic Blood Pressure (mm Hg)

619

79.1 (10.7)

78.6 (10.5)

-0.5 (9.0)

0.196

170

90.7 (10.7)

85.7 (11.8)

-5.1 (9.3)

<0.001

Cholesterol (mg/dl)

606

189.7 (38.8)

186.1 (37.7)

-3.5 (21.9)

< .001

215

231.0 (25.7)

218.9 (34.2)

-12.1 (25.4)

<0.001

Knowledge

470

75.6 (18.6)

82.4 (16.7)

6.8 (14.6)

< .001

103

45.8 (11.6)

64.7 (22.3)

18.8

< .001

Notes
1

Knowledge is presented as percentage correct of 20 items.

https://doi.org/10.1371/journal.pone.0248473.t003

increasing health literacy, and overall healthier food choices and more physical activity. This is
in contrast to other compared studies including DPP, which aimed for seven percent weight
loss [26], and Vivamos Activos, which focused on tailored weight loss [28]. Like VSP, the
Latinx modified DPP focused on healthy food choices, and, “Latinos en Control,” which
focused on diabetes knowledge and healthy food choices [23].
Waist circumference, a key indicator of MetS, is not often included in intervention studies
focused on cardiometabolic factors. WC decreased by 0.4 inches among the entire VSP group,
and slightly more (0.5 inches) among those starting CSP with an elevated WC. In the HELP
Prevent Diabetes Trial, adapted from DPP and focusing on weight loss, participants achieved
larger decreases with a loss of 2.6 inches at 12 months, which were sustained to 1.6 inches at 24
months [22]. No change in WC was reported [23, 26, 27] or WC was not measured [28] for
other cardiometabolic studies reviewed here.
Changes in indicators of diabetes risk or metabolic syndrome among VSP participants compare quite favorably with other similar, but longer and more intensive interventions. A1C
declined by 0.2g/dl for all VSP participants, 0.3 g/dl for the high-risk group, which was a slightly
smaller improvement than for the more intensive DPP adapted for Latinos (a between group
decrease in blood glucose of 0.5 g/dl at 4 months) [27]. Among those beginning VSP with elevated blood glucose levels, a reduction of 8.3 mg/dL in blood glucose was observed, which was
slightly greater than the changes seen in the HELP Prevent Diabetes Trial, where participants
averaged a significant decrease of 2.9 mg/dl at 12 months and 4.4 mg/dl at 24 months [22].

PLOS ONE | https://doi.org/10.1371/journal.pone.0248473 April 1, 2021

9 / 16

PLOS ONE

PLOS ONE | https://doi.org/10.1371/journal.pone.0248473 April 1, 2021

Results of the ‘Vida Sana/Healthy Life’ program

10 / 16

PLOS ONE

Results of the ‘Vida Sana/Healthy Life’ program

Fig 1. Changes in clinical and chemical indicators for participants with high risk baseline values from baseline to 8
weeks post Vida Sana initiation.
https://doi.org/10.1371/journal.pone.0248473.g001

Few cardiometabolic-focused interventions have assessed lipid levels. Among VSP participants, total cholesterol levels improved (-3.5 for all and -12.1 for those at high risk), which was
similar to or better than other programs. The Vivamos Activos program found small decreases
(<5 mg/dl) among all study groups at 6 months, but no differences between groups [28]. Others did not measure total cholesterol [22, 27], but saw improvements in triglyceride and HDL
levels [22], while others saw no significant intervention effect on lipids [23, 29].
Few studies addressing hyperlipidemia risk have also targeted metabolic risk or blood pressure. Blood pressure improved minimally among the whole sample, but significantly with a
drop of 6.0 mmHg systolic and 5.1 mmHg for diastolic among the high-risk VSP participants.
Other studies have found minimal [22] or no change [29], or did not measure blood pressure
change.
In addition to clinical measures and chemistries, VSP also assesses knowledge of concepts
related to nutrition and clinical indicators for chronic disease. The scores of this assessment
improved substantially throughout the program, with the general group of VSP participants
scoring 10 points higher at the Week 8 time point, and a more than 30-point increase observed
among those with lower scores to start. This measure is particularly useful as it is conducted
using pictures and symbols that require minimal literacy skills; however, mean scores at baseline were already relatively high indicating little room for improvement in knowledge. Few
other studies have examined changes in health knowledge, especially in this way. The Latina
Preventive Heart Disease Program conducted an assessment of CVD-related knowledge,
including knowledge of heart attack symptoms, when to call 911, and CVD risk factors; they
found significant increases in knowledge between the pre- and post-intervention survey [30].
Using the “Audit of Diabetes Knowledge,” [31] the Latinos En Control intervention study
showed significant increases in participants’ knowledge at 4 months and 1-year post-intervention as compared with patients receiving usual care [23].
The lower weight reduction attained by VSP may be due to the shorter time frame of the
intervention, the lower intensity of the intervention, or different content (less focused on
weight loss) compared with the other studies reviewed. Though clinically significant weight
reduction was not appreciably achieved in VSP, the changes in glucose, cholesterol and blood
pressure were comparable or better than other more intensive studies, demonstrating that
some behavioral change has occurred. The VSP study did not measure reported changes in
physical activity or diet, which may or may not have occurred. Also, it is possible that behavioral change may have occurred in the form of medication compliance, which was also not
measured. Increasing the duration or intensity of the short VSP program might result in better
results, including more weight change, but those changes would be at the risk of lower retention due to increased participant burden.
Of the participants present for the baseline evaluation, 62% were present for the final class
evaluation. Of the initially enrolled sample, 70% attended four or more classes (half of the
course), but only 30% attended all eight classes. The retention rate, though not extraordinary,
is comparable to others that ranged from 27.6–96% in a review of 9 RCTs that targeted Latino
adults (mostly only women) [32]. The VSP study provided a $10 incentive at baseline and at 8
and 12 week follow-up evaluation time points; the DPP adapted for Hispanic adults, which
offered an incentive of $25 at baseline and 6 months evaluations, and $50 at one year, reported
a 1-year retention of 94% [27]. The HELP Prevent Diabetes Trial saw 92% retention at
6-months and 84% retention at 24-months [22]. Vivamos Activos saw a median of 12 sessions
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attended out of 16 (75%) attended [28]. In the Latinos en Control program, 68% of participants
attended more than 6 of the 12 total sessions [23]. These are comparable to the attendance for
VSP. VSP has both strengths and weakness that need to be discussed. As has been mentioned,
VSP is a somewhat low-intensity, 1.5 hour meetings weekly over eight weeks. Retention was
moderate compared to other studies as described above. Retention rates were not equal for all
populations within the VSP program. Moving forward, we plan to assess the reasons that certain groups were less likely to partake in or complete the intervention through surveys and
direct outreach. For example, male participants were more likely to drop out of the program
than female participants, which has been seen in many other public health interventions [33].
Lower completion among participants with high A1c or glucose at baseline is also concerning.
One possible explanation for this is that the structural barriers that led to poorer health at baseline, including challenges with transportation or childcare, also prevented participants from
fully engaging in the class. In the future, we may want to evaluate some of these factors to see
which drive patients to leave the class and discover ways to improve retention.
The catchment for this study is a convenience patient group at a single community clinic
mainly utilized by the Hispanic patients of Caribbean, Central and South American origin and
the surrounding neighborhood. Thus, the results may not be generalizable beyond similar clinics. Additionally, the evaluation protocol could be improved to measure and better understand
VSP participant dietary and physical activity changes. Other comparable studies have included
measures of physical activity [34], diet [26, 27], measures of inflammatory markers [30] and
assessment of depressive symptoms [27–29]. An enhanced evaluation protocol might consider
the addition of these factors along with assessment of medication adherence and other clinical
compliance (e.g. self-monitoring of blood glucose, etc.). Longer-term follow up visits, such as
at 6 months or 1 year after the program, may provide more robust data and allow us to determine the durability of the program’s effects.
Another limitation is the fact that sessions often occurred in the evenings, so glucose and
lipids had to be measured after 4 hours of fasting instead of the standard 8 hours. These pointof-care tests are a limitation in themselves; while previous studies have shown that values do
not differ significantly [35] between fingerstick point-of-care and serum laboratory testing of
glucose, a single glucose or cholesterol reading may not be representative of a patient’s overall
clinical picture. This may alter values slightly, but we were fortunately able to measure A1c as
well, which provides a more reliable, longitudinal measure in the case of blood glucose.
A consistent concern for non-profit community organizations and free clinics is cost effectiveness and long-term sustainability. Overall, the costs of this program are relatively low,
thanks in large part to the fact that CEHC is staffed mostly by volunteers. Direct costs, estimated at $5,000-$7,500 per class for 15–20 participants ($250-$500 per person), which
includes Navegante salaries, printing, incentives, and clinical measurement supplies, and
administrative costs include project coordination and financial management time. CEHC continuously seeks outside investment in this program, including collaboration with other health
management initiatives through state and private entities that are geared towards low-income
communities. By demonstrating the effectiveness and culturally appropriate nature of our program to funders and stakeholders, we are able to offer the program to participants who would
not be able to afford a commercially available program.
The intervention curriculum focused on many aspects of obesity, lipids, blood pressure and
diabetes, with guidelines for diet, physical activity, and medication compliance. An enhanced
version might be strengthened with theory-based behavior change components and accompanying evaluation. Additionally, interventions in the literature have included home visits and
individual meetings to set goals and provide one-on-one case management [27], which is a
broader scope than the follow-up phone calls that take place in VSP. Other interventions have
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also included coach-facilitated online group sessions or social media enhancements [36]; components that could be considered with or without Navegante presence for future enhancement
of VSP. Future work should focus on increasing participant engagement throughout the intervention to strengthen the overall fidelity to the program design by improving the dose
received. A randomized trial or other study design including a comparison or control group
would also allow for better assessment of the intervention compared with outcomes of patients
who might be motivated for change after a clinical diagnosis or discussion, but without this
specific program for guidance.
The strengths of this study are also important to acknowledge. Participants anecdotally
reported appreciation for the program, with particular enjoyment of the social connection and
community-building that occurred, in addition to the individual attention of the Navegantes.
The “social club” style seems to be a unique style of employing CHWs, which engaged participants with low-commitment emphasis, but also served in community-building. The style and
client appreciation underscore the fact that this research is comprised of evaluation of a clinicbased program, not a funded research protocol. Other studies that also use CHWs describe
some form of social engagement, but the non-classroom, fun activities may be unique to VSP.
Also, VSP focused on a broad set of chronic disease risks, expanding beyond traditional focus
on just diabetes or cardiovascular risk separately. While there are many external factors that
may have impacted results, the enrollment of well over 600 participants for this small, clinicbased program is considerable, indicating the need and potentially strong benefit for VSP and
the utility of further translational research.
It is important note that the participants in the Vida Sana program are among the lowest
income individuals living in Providence, Rhode Island, and they face numerous structural
inequities that negatively impact their health and access to health care. They do not speak
English as their first language, work multiple jobs, lack reliable sources of food and transportation, and live in crowded multi-tenant housing. Their ability to improve their own health is
limited by these circumstances, and community interventions like ours can unfortunately not
address the many systemic factors at play. However, it appears that despite substantial barriers
to improving health, providing participants with new tools and information may empower
them to reclaim some control over their health. These acquired skills could have a long lasting
effect.
In sum, the VSP shows encouraging improvements in clinical metabolic parameters for
participating members of the CEHC community, especially given the limited intensity and
scale of the intervention. Future research may continue this important work by carefully
expanding the intervention and evaluation, but without losing the strong community engagement. Future research should include assessment of cost effectiveness, strengthening retention
rates in certain sub-populations (including men and those with high baseline A1c), further
assessment of diet, physical activity and medication compliance, and exploration of the social
connection between participants and Navegantes.
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